Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas

Journal of Molecular Histology

Volumn 36, Issue 8-9, 2005, Pages 447-454

  Mukdsi, Jorge Humberto ^a   Paul, Ana Lucía De ^a   Gutiérrez, Silvina ^a   Roth, Félix Daniel ^a   Aoki, Agustín ^a   Torres, Alicia Inés ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; VASCULOTROPIN;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL ORGANELLE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ENDOPLASMIC RETICULUM; EUCHROMATIN; GOLGI COMPLEX; HYPOPHYSIS CELL; IMMUNODETECTION; IMMUNOLOCALIZATION; MALE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROLACTINOMA; RAT; STELLATE CELL; TUMOR GROWTH; ULTRASTRUCTURE; WESTERN BLOTTING;

EID: 33744831491     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-005-9012-7     Document Type: Article

References (42)

1. Banerjee S, Sarkar D, Weston A, De A, Campbell D (1997) Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumours may mediate estrogen-initiated tumour angiogenesis. Carcinogenesis 18: 1155-1161.
2. Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR (2000) Over expression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 16: 253-260.
3. Cristina C, Diaz-Torga G, Baldi A, Gongora A, Rubinstein M, Low MJ, Becu-Villalobos D (2005) Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice. Endocrinology 146: 2952-2962.
4. Chen J, Braet F, Brodsky S, Weinstein T, Romanov V, Noiri E, Goligorsky MS (2002) VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells. Am J Physiol Cell Physiol 282: 1053-1063.
5. Cracchiolo D, Swick J, McKiernan L, Sloan E, Raina S, Sloan C, Wendell D (2002) Estrogen-dependent growth of a rat pituitary tumour involves, but does not require, a high level of vascular endothelial growth factor. Exp Biol Med 227: 492-499.
6. Ezzat S (2001) The role of hormone, growth factors and their receptors in pituitary tumorigenesis. Brain Pathol 11: 356-370.
7. Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858.
8. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13: 18-32.
9. Ferrara N, Smyth-Davis T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
10. Fukui S, Nawashiro H, Otani N, Ooigawa H, Yano A, Nomura N, Tokumaru AM, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S, Shima K (2003) Vascular endothelial growth factor expression in pituitary adenomas. Acta Neurochir Suppl 86: 519-521.
11. Gerber HP, Ferrara N (2003) The role of VEGF in normal and neoplastic hematopoiesis. J Mol Med 81: 20-31.
12. Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N (2002) VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417: 954-958.
13. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S (1999) Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5: 1317-1321.
14. Heaney A, Fernando M, Melmed S (2002) Functional role of estrogen in pituitary tumour pathogenesis. J Clin Invest 109: 277-283.
15. Hovarth E, Kovacs K, Schithauer B (1999) Pituitary hyperplasia. Pituitary 1: 169-180.
16. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM (2000) Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60: 3183-3190.
17. Iborra FJ, Jackson DA, Cook PR (2001) Coupled transcription and translation within nuclei of mammalian cells. Science 293: 1139-1142.
18. Iborra FJ, Jackson DA, Cook PR (2004) Approaches for monitoring nuclear translation. Methods Mol Biol 257: 103-114.
19. Itoh J, Serizawa A, Kawai K, Ishii Y, Teramoto A, Osamura Yoshiyuki R (2003) Vascular networks and endotelial cells in rat experimental pituitary glands and in the human pituitary adenomas. Micros Res Tech 60: 231-235.
20. Katoh R (2003) Angiogenesis in endocrine glands: special reference to the expression of vascular endothelial growth factor. Microsc Res Tech 60: 181-185.
21. Kerbel R (2000) Tumour angiogenesis: past, present and the near future. Carcinogenesis 21: 505-515.
22. Lejbkowicz F, Goldberg-Cohen I, Levy AP (2005) New horizons for VEGF. Is there a role for nuclear localisation? Acta Histochem 106: 405-411.
23. Li W, Keller G (2000) VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells. J Cell Sci 113: 1525-1534.
24. Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L (1999) Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10: 229-235.
25. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla G, Renner U (2001) Vascular endothelial growth factor production and regulation in rodent and human pituitary tumour cells in vitro. Neuroendocrinology 74: 95-105.
26. Maldonado C, Aoki A (1986) Improvement of prolactin immunolabeling in osmium-fixed acrylic-embedded pituitary gland. Bas Appl Histochem 30: 301-305.
27. Mukdsi JH, De Paul AL, Muñoz S, Aoki A, Torres AI (2004) Immunolocalisation of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen. Histochem Cell Biol 121: 453-462.
28. Ochoa A, Mitchner N, Paynter C, Morris R, Ben-Jonathan N (2000) Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen. J Endocrinol 165: 483-492.
29. Onofri C, Carbia Nagashima A, Schaaf L, Feirer M, Lohrer P, Stummer W, Berner S, Chervin A, Goldberg V, Stalla GK, Renner U, Arzt E (2004) Estradiol stimulates vascular endothelial growth factor and interleukin-6 in human lactotroph and lactosomatotroph pituitary adenomas. Exp Clin Endocrinol Diabetes 112: 18-23.
30. Pombo A, Jackson DA, Hollinshead M, Wang Z, Roeder RG, Cook PR (1999) Regional specialization in human nuclei: visualization of discrete sites of transcription by RNA polymerase III. EMBO J 18: 2241-2253.
31. Re RN (2002) Toward a theory of intracrine hormone action. Regul Pepr 106: 1-6.
32. Re RN (2003) The intracrine hypothesis and intracellular peptide hormone action. Bioessays 25: 401-409.
33. Rosenbaum-Dekel Y, Fuchs A, Yakirevich E, Azriel A, Mazareb S, Resnick MB, Levi B-Z (2005) Nuclear localisation of long-VEGF is associated with hypoxia and tumor angiogenesis. Biochem Biophys Res Commun 332: 271-278.
34. Schedlich LJ, Young TF, Firth SM, Baxter RC (1998) Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273: 18347-18352.
35. Spada A, Lania A (2002) Growth factors and human pituitary adenomas. Mol Cell Endocrinol 197: 63-68.
36. Sugawara A, Yen PM, Darling DS, Chin W (1993) Characterization and tissue expression of multiple triiodothyronine receptorauxiliary proteins and their relationship to the retinoid X-receptor. Endocrinology 133: 965-971.
37. Takada K, Yamada S, Teramoto A (2004) Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas. Endocr Pathol 15: 131-139.
38. Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24: 600-632.
39. Viacava P, Gasperi M, Acerbi G, Manetti L, Cecconi E, Bonadio AG, Naccarato AG, Acerbi F, Parenti G, Lupi I, Genovesi M, Martino E (2003) Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas. J Endocrinol Invest 26: 23-28.
40. Vidal S, Horvath E, Kovacs K, Lloyd R, Smyth H (2001) Reversible transdifferentiation: interconversion of somatotrophs and lactotrophs in pituitary hyperplasia. Mod Pathol 14: 20-28.
41. Vidal S, Lloyd RV, Moya L, Scheithauer BW, Kovacs K (2002) Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary. J Histochem Cytochem 50: 533-540.
42. Vidal S, Oliveira M, Kovacs K, Scheithauer B, Lloyd R (2000) Immunolocalisation of vascular endothelial growth factor in the GH3 cell line. Cell Tissue Res 300: 83-88.